Key regions: Australia, Italy, France, South Korea, Brazil
Nicaragua, a Central American country known for its stunning landscapes, has been experiencing a growth in its healthcare sector in recent years. This growth is also reflected in the vaccines market, which has been showing some interesting trends.
Customer preferences: The country's population has been increasingly aware of the importance of vaccination, which has resulted in a growing demand for vaccines. Nicaraguans are particularly interested in vaccines that protect against common illnesses such as influenza, pneumonia, and hepatitis.
Trends in the market: The vaccines market in Nicaragua has been growing steadily, driven by the government's efforts to expand access to healthcare services. The country has been investing in its healthcare infrastructure, which has helped to increase the availability of vaccines in both urban and rural areas. Additionally, the private sector has been playing an important role in the distribution of vaccines, particularly for those that are not covered by the government's vaccination program.
Local special circumstances: One of the unique aspects of the vaccines market in Nicaragua is the country's vulnerability to natural disasters. Nicaragua is located in an area that is prone to hurricanes, earthquakes, and volcanic eruptions, which can disrupt the supply and distribution of vaccines. As a result, the government has been working to improve its disaster preparedness and response, which includes ensuring the availability of essential medicines and vaccines.
Underlying macroeconomic factors: Nicaragua's economy has been growing steadily in recent years, which has helped to support the development of its healthcare sector. However, the country still faces challenges related to poverty and inequality, which can impact access to healthcare services, including vaccines. The government has been working to address these issues through social programs and policies aimed at reducing poverty and improving access to healthcare.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
